Brookline Capital Management Weighs in on Adial Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:ADIL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Declines By 37.4% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Adial Pharmaceuticals (ADIL) to Release Earnings on Monday kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 416,400 shares, an increase of 42.6% from the April 15th total of 292,100 shares. Based on an average trading volume of 682,600 shares, the […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research issued their FY2023 EPS estimates for Adial Pharmaceuticals in a report released on Monday, April 3rd. Litchfield Hills Research analyst T. O’neill anticipates that the company will earn ($0.49) per share for the year. The consensus estimate for Adial Pharmaceuticals’ […]